Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Oxadiazole-containing heterocyclic compounds, and preparation method and application thereof

A technology of compounds and heterocycles, applied in the field of oxadiazole-containing heterocycles and their preparation and application, can solve the problems of poor curative effect of leukemia

Inactive Publication Date: 2016-12-07
TIANJIN INT JOINT ACADEMY OF BIOTECH & MEDICINE
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] In order to solve the problem of poor curative effect of drugs used to treat leukemia in the prior art, according to one aspect of the present invention, an oxadiazole-containing heterocyclic compound is provided, and the oxadiazole-containing heterocyclic compound has the following properties: General structural formula:

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Oxadiazole-containing heterocyclic compounds, and preparation method and application thereof
  • Oxadiazole-containing heterocyclic compounds, and preparation method and application thereof
  • Oxadiazole-containing heterocyclic compounds, and preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0088] Example 1 Chemical synthesis and structural identification of oxadiazole-containing heterocyclic compounds provided by the present invention

[0089] 1. The oxadiazole-containing heterocyclic compound provided by the present invention has the following general structural formula:

[0090]

[0091] In the above general structural formula, the substituent -R includes the following groups:

[0092]

[0093] 2. The experimental procedures of chemical synthesis of heterocyclic compounds containing oxadiazole provided by the present invention:

[0094] 2.1 The general synthetic route is:

[0095]

[0096] 2.2.1 Synthesis of compound 5a-5h

[0097] 2.2.1.1 Compound 2: Synthesis of 4-methyl-3-[4-(pyridin-3-yl)pyrimidinyl-2-yl]aminobenzoic acid methyl ester

[0098]

[0099] Add 30mL of anhydrous methanol, compound 1 (1g, 3.26mmol) into a three-necked flask, slowly drop 2mL of concentrated sulfuric acid into it, after the addition is complete, the reaction solution is heated to reflux at 65...

example 1-8

[0142] Example 1-8 Synthesis of Compound 6a-6h

[0143]

example 1

[0144] Example 1 Compound 6a: N-(2-methyl-5-{5-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-1, Synthesis and structure identification of 3,4-oxadiazol-2-yl)phenyl)-4-(3-pyridyl)-pyrimidin-2-amine

[0145]

[0146] Add 167 mg of triphenoxy phosphine and 2 mL of dry dichloromethane to a three-necked flask, slowly add 50 μL of trifluoromethanesulfonic anhydride at 0°C, stir at 0°C for 5 min, and slowly rise to room temperature, a white solid is formed , Add compound 5a (114.5mg, 0.2mmol), the solution turns into bright yellow, stir the reaction at room temperature for 3h, then use 10% NaHCO 3 The aqueous solution was quenched, the aqueous layer was extracted with dichloromethane, and the dichloromethane layer with anhydrous Na 2 SO 4 Dry, filter, spin off the solvent from the filtrate, and purify the residue by column chromatography with CH 2 Cl 2 :MeOH=50:1,CH 2 Cl 2 : MeOH=30:1 gradient elution to obtain 65 mg of white solid, yield: 58.61%.

[0147] MS(ESI + ): 554.98; ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides oxadiazole-containing heterocyclic compounds, and a preparation method and an application thereof. The oxadiazole-containing heterocyclic compounds have a structural general formula shown in the description. Cell level experiments find that the oxadiazole-containing heterocyclic compounds can inhibit proliferation of K562-3d, HL60 and KG1a cells, and especially the compound (compound 10c) in the embodiment 11 also realize K562-3d, HL60 and KG1a cell proliferation inhibition effects when the concentration of the compound 10c is lower than a that of a positive control medicine imatinib, so the oxadiazole-containing heterocyclic compounds can be used for treating leukemia.

Description

Technical field [0001] The invention relates to an oxadiazole-containing heterocyclic compound and a preparation method and application thereof. Background technique [0002] Leukemia, also known as blood cancer, is a type of clonal malignant disease with abnormal hematopoietic stem cells. The leukemia cells in the clone lose the ability to further differentiate and mature and are stagnated at different stages of cell development. In the bone marrow and other hematopoietic tissues, leukemia cells proliferate and accumulate in large numbers and infiltrate other organs and tissues, while suppressing normal hematopoiesis. The clinical manifestations are symptoms of anemia, bleeding, infection and infiltration of various organs. [0003] Leukemia is usually divided into: 1) acute leukemia; 2) chronic leukemia; 3) special types of leukemia. [0004] Acute leukemia is a clonal malignant disease with abnormal hematopoietic stem cells. The leukemia cells in the clone lose the ability to f...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07D413/14A61K31/506A61P35/02
Inventor 饶子和杨诚陈悦白翠改孙涛王静晗李永涛潘成文孟凡非管文豪
Owner TIANJIN INT JOINT ACADEMY OF BIOTECH & MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com